Center-Authored Papers

Filters: Author is Hampel, Heather  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
United States
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Shared Resources
Jones KA, Kim PD, Patel BB, Kelsen SG, Braverman A, Swinton DJ, Gafken PR, Jones LA, Lane WS, Neveu JM et al..  2013.  Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite/LTQ-Orbitrap Velos/Q exactive mass spectrometers.. Journal of proteome research. 12(10):4351-65. Abstract
Sex Factors
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Sex Distribution
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Sensitivity and Specificity
Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA et al..  2012.  Identification of Lynch syndrome among patients with colorectal cancer.. JAMA : the journal of the American Medical Association. 308(15):1555-65. Abstract
Risk Factors
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Risk Assessment
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Registries
Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA et al..  2012.  Identification of Lynch syndrome among patients with colorectal cancer.. JAMA : the journal of the American Medical Association. 308(15):1555-65. Abstract
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Public Health Sciences Division
Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA et al..  2012.  Identification of Lynch syndrome among patients with colorectal cancer.. JAMA : the journal of the American Medical Association. 308(15):1555-65. Abstract
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Burt RW, Cannon JA, David DS, Early DS, Ford JM, Giardiello FM, Halverson AL, Hamilton SR, Hampel H, Ismail MK et al..  2013.  Colorectal cancer screening.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(12):1538-75. Abstract
Proto-Oncogene Proteins B-raf
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Proteomics Core Facility
Jones KA, Kim PD, Patel BB, Kelsen SG, Braverman A, Swinton DJ, Gafken PR, Jones LA, Lane WS, Neveu JM et al..  2013.  Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite/LTQ-Orbitrap Velos/Q exactive mass spectrometers.. Journal of proteome research. 12(10):4351-65. Abstract
Polymerase Chain Reaction
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
PHENOTYPE
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Penetrance
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Ohio
Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA et al..  2012.  Identification of Lynch syndrome among patients with colorectal cancer.. JAMA : the journal of the American Medical Association. 308(15):1555-65. Abstract
Odds Ratio
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
November 2012
Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA et al..  2012.  Identification of Lynch syndrome among patients with colorectal cancer.. JAMA : the journal of the American Medical Association. 308(15):1555-65. Abstract
New Zealand
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Neoplasms
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Mutagenesis, Insertional
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract